CClinicalTrials.gg
CompletedNCT06000384Updated Aug 11, 2025

Is Ultrasound Comparable to Chest X-ray in Verification of Intensive Care Patients Enteral Feeding Tube Positioning.

An observational study in Intensive Care Patient, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-11.

Sponsored by Norwegian University of Science and Technology · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
15
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to investigate methodological if ultrasound is comparable to chest X-ray in verification of intensive care patients enteral feeding tube positioning.

The main question to answer is: Is ultrasound a comparable method to chest X-ray in verification of intensive care patients enteral feeding tube positioning.

Read the detailed description

In Norway, around 4000 patients are yearly in need of ventilator, and many of them will need enteral nutrition through a feeding tube. 40 % of all intensive care patients have signs of malnutrition. If ultrasound is a comparable method to chest X-ray in verification of intensive care patients enteral feeding tube positioning, then enteral nutrition in many cases can be started several hours earlier than using chest X-ray verification. The ultrasound examination will be performed in a research based in a 4-step approach. In this project 20-30 intensive care patients prescribed by a medical physician to have an enteral feeding tube will be included in the project due to written informed consent by 1) Awake intensive care patient or by 2) Patients informal caregiver if the patient is not competent to consent.

02

Conditions studied

  • Intensive Care Patient

Keywords

  • Intensive care patient
  • Enteral feeding tube
03

In context

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Intensive care patients in need of enteral tube feeding

Inclusion criteria

  • Intensive care patient prescribed by a medical physician to have an enteral feeding tube

Exclusion criteria

Exclusion Criteria:

  • \<18 years
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
15 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Measuring enteral tube position both by standard chest X-ray and ultrasound

    Ultrasound measure by a research based 4-step approach

    Time frame: maximum five minutes for each method

07

Study locations

1 site
  • Lillehammer sykehus, Sykehuset Innlandet
    Lillehammer, Innlandet 2609, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06000384
Lead sponsor
Norwegian University of Science and Technology
Responsible party
Sponsor
First posted
Aug 21, 2023
Start date
Sep 26, 2023
Primary completion
Feb 27, 2024
Completion
Feb 27, 2024
Last update
Aug 11, 2025

Study contacts

Irene Lie, Professor
principal investigator · Norwegian University of Science and Technology - NTNU.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion